SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-23-039343
Filing Date
2023-08-14
Accepted
2023-08-11 21:13:28
Documents
18
Period of Report
2023-05-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc20057283_8ka.htm   iXBRL 8-K/A 38524
2 EXHIBIT 23.1 brhc20057283_ex23-1.htm EX-23.1 3534
3 EXHIBIT 99.1 brhc20057283_ex99-1.htm EX-99.1 873656
4 EXHIBIT 99.2 brhc20057283_ex99-2.htm EX-99.2 844525
5 EXHIBIT 99.3 brhc20057283_ex99-3.htm EX-99.3 759858
9 logo_bakertilly-usllp.jpg GRAPHIC 25279
10 sig_btilly.jpg GRAPHIC 25006
  Complete submission text file 0001140361-23-039343.txt   2895928

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eltx-20230531.xsd EX-101.SCH 3859
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltx-20230531_lab.xml EX-101.LAB 23290
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltx-20230531_pre.xml EX-101.PRE 16548
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc20057283_8ka_htm.xml XML 4227
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39990 | Film No.: 231165887
SIC: 2834 Pharmaceutical Preparations